Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin-TCF association

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 22, 2003, Pages 12584-12589

  Nath, Niharika ^a   Kashfi, Khosrow ^a   Chen, Jie ^b   Rigas, Basil ^b  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (ACETYLOXY)BENZOIC ACID 2 (NITROOXYMETHYL)PHENYL ESTER; 2 (ACETYLOXY)BENZOIC ACID 3 (NITROOXYMETHYL)PHENYL ESTER; 2 (ACETYLOXY)BENZOIC ACID 4 (NITROOXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; BETA CATENIN; NCX 4040; NCX 4060; NITRIC OXIDE; NITRIC OXIDE DONATING ASPIRIN; T CELL FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL NUCLEUS; CHEMOPROPHYLAXIS; COLON CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYCLIN D1 GENE; GENE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; ISOMERISM; LUCIFERASE GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TARGET GENE; TRANSCRIPTION INITIATION;

ASPIRIN; BETA CATENIN; CADHERINS; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; GENES, REPORTER; HUMANS; LUCIFERASES; NITRIC OXIDE DONORS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0242300130     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.2134840100     Document Type: Article

References (17)

1. Gustin, D. M. & Brenner, D. E. (2002) Cancer Metastasis Rev. 21, 323-348.
2. Levy, R. (2002) N. Engl. J. Med. 347, 615.
3. Rigas, B. & Williams, J. L. (2002) Int. J. Oncol. 20, 885-890.
4. Fiorucci, S., Santucci, L., Gresele, P., Faccino, R. M., Del Soldato, P. & Morelli, A. (2003) Gastroenterology 124, 600-607.
5. Moon, R. T., Bowerman, B., Boutros, M. & Perrimon, N. (2002) Science 296, 1644-1646.
6. Dihlmann, S., Siermann, A. & von Knebel Doeberitz, M. (2001) Oncogene 20, 645-653.
7. Williams, J. L., Borgo, S., Hasan, I., Castillo, E., Traganos, F. & Rigas, B. (2001) Cancer Res. 61, 3285-3289.
8. Kashfi, K., Ryann, Y., Qiao, L. L., Williams, J. L., Chen, J., Del Soldato, P., Traganos, F. & Rigas, B. (2002) J. Pharmacol. Exp. Ther. 303, 1273-1282.
9. Bak, A. W., McKnight, W., Li, P., Del Soldato, P., Calignano, A., Cirino, G. & Wallace, J. L. (1998) Life Sci. 62, L367-L373.
10. Natarajan, K., Singh, S., Burke, T. R., Jr., Grunberger, D. & Aggarwal, B. B. (1996) Proc. Natl. Acad. Sci. USA 93, 9090-9095.
11. Chapple, K. S., Cartwright, E. J., Hawcroft, G., Tisbury, A., Bonifer, C., Scott, N., Windsor, A. C., Guillou, P. J., Markham, A. F., Coletta, P. L. & Hull, M. A. (2000) Am. J. Pathol. 156, 545-553.
12. Utsunomiya, T., Doki, Y., Takemoto, H., Shiozaki, H., Yano, M., Sekimoto, M., Tamura, S., Yasuda, T., Fujiwara, Y. & Monden, M. (2001) Oncology 61, 226-233.
13. Heinen, C. D., Goss, K. H., Cornelius, J. R., Babcock, G. F., Knudsen, E. S., Kowalik, T. & Groden, J. (2002) Gastroenterology 123, 751-763.
14. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. & Kinzler, K. W. (1997) Science 275, 1787-1790.
15. Jaiswal, A. S., Marlow, B. P., Gupta, N. & Narayan, S. (2002) Oncogene 21, 8414-8427.
16. Fuchs, S. Y. (2002) Cancer Biol. Ther. 1, 337-341.
17. Richter, M., Weiss, M., Weinberger, I., Furstenberger, G. & Marian, B. (2001) Carcinogenesis 22, 17-25.